Irish Times – Irish pharma company closes $64m financing round

Please link to the article by Charlie Taylor below which was posted in May 2018 by website.

Sigmoid Pharma – now known as Sublimity Therapeutics has closed an enormous $64m round of financing. This large investment is to fund the clinical development of a drug to treat patients with moderate to severe ulcerative colitis. The drug is a soluble formulation which has been indicated as a safe, effective treatment for several inflammatory diseases including psoriasis and Crohn’s disease.

You can access further information reading the full article by clicking on the button below.

Share This Post!

Recent Posts

News Archive

If you are interested in becoming an Investor or seeking investment, then please contact us.